Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2013 Mar 6;86(2):292–297. doi: 10.1016/j.ijrobp.2013.01.028

Figure 3.

Figure 3

FA maps of a medulloblastoma patient (male, baseline age 11 years) acquired at baseline (a) and the two follow-up times of 18 months (b) and 45 months (c) from baseline. The white arrows indicate dTPF showing more pronounced FA reduction than the other regions.